2017

MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina

Genomics research and diagnostics company aims to accelerate biomarker discovery by leveraging the genetic diversity of the Indian population FOSTER CITY, Calif., Aug. 28, 2017 /PRNewswire/ — MedGenome, a leading genomics research and diagnostics company, announced completion of $30 million in Series C financing led by Sequoia India and Sofina s.a., with participation by Zodius […]

MedGenome to present insights into the impact of CD8 T-cell infiltration on patient survival

The poster will be presented at ‘Frontiers in Cancer Immunotherapy’ conference in New York FOSTER CITY, CA, UNITED STATES, February 8, 2017 /EINPresswire.com/ — MedGenome will present a poster titled “Tumor microenvironment analysis provides insights into the activity of CD8 T-cells and their impact on survival.” at the Frontiers in Cancer Immunotherapy conference organized by

Michael A. Nemzek appointed as MedGenome Chief Commercial Officer

Key appointment to strengthen company’s expansion efforts FOSTER CITY, CA, UNITED STATES, January 9, 2017 /EINPresswire.com/ — MedGenome, a genomics-driven research and diagnostics company based in Foster City, California, today announced the appointment of Michael A. Nemzek as its Chief Commercial Officer. Mr. Nemzek has held executive senior leadership team positions in both public companies